Chest PNF on Pulmonary Function in Parkinson Disease

Parkinson Disease Clinical Trial

Official title: Efficacy of Chest PNF on Pulmonary Function in Patients With Parkinson's Diseases

Status Recruiting

Clinical Trial Summary

Background: Parkinson disease (PD) is a progressive neurodegenerative disorder and characterized by tremor, rigidity and bradykinesia. Almost 84% of PD patient develops respiratory abnormalities and pointed as the most common cause of death. Airway obstruction, trunk muscle rigidity is the common cause of respiratory abnormalities.

Purpose: The main purpose of the study will evaluate the efficacy of chest PNF on pulmonary function and chest wall mobility in PD.

Methods: 20 participants will be recruited for study purpose and divide into two groups. Group= A will be the control group and participants will receive conventional treatment which includes deep breathing exercise and segmental breathing exercise, incentive spirometry etc for one week. Group= B participants will receive chest PNF exercise along with conventional treatment for a week. Pretreatment and post-treatment data will be recorded by the help of PFT (FVC, FEV1 & FEV1/FVC) and chest wall expansion at axillary and xiphisternal level for data analysis. Data analysis will be done by paired t-test for within group and independent t-test will be used for the between-group variable. The level of significance will be set at 0.05.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Parkinson Disease

• NCT number: NCT03977740
• Study type: Interventional
• Source: Maharishi Markendeswar University
• Contact: Mousumi Saha, MPT
• Phone: 9366787310
• Email: msaha0029@gmail.com
• Status: Recruiting
• Phase: N/A
• Start date: January 1, 2018
• Completion date: June 10, 2019